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Abstract
Human African trypanosomiasis or sleeping sickness is a vector-borne parasitic disease that has a major impact on human
health and welfare in sub-Saharan countries. Based mostly on data from animal models, it is currently thought that
trypanosome entry into the brain occurs by initial infection of the choroid plexus and the circumventricular organs followed
days to weeks later by entry into the brain parenchyma. However, Trypanosoma brucei bloodstream forms rapidly cross
human brain microvascular endothelial cells in vitro and appear to be able to enter the murine brain without inflicting
cerebral injury. Using a murine model and intravital brain imaging, we show that bloodstream forms of T. b. brucei and
T. b. rhodesiense enter the brain parenchyma within hours, before a significant level of microvascular inflammation is
detectable. Extravascular bloodstream forms were viable as indicated by motility and cell division, and remained detectable
for at least 3 days post infection suggesting the potential for parasite survival in the brain parenchyma. Vascular
inflammation, as reflected by leukocyte recruitment and emigration from cortical microvessels, became apparent only with
increasing parasitemia at later stages of the infection, but was not associated with neurological signs. Extravascular
trypanosomes were predominantly associated with postcapillary venules suggesting that early brain infection occurs by
parasite passage across the neuroimmunological blood brain barrier. Thus, trypanosomes can invade the murine brain
parenchyma during the early stages of the disease before meningoencephalitis is fully established. Whether individual
trypanosomes can act alone or require the interaction from a quorum of parasites remains to be shown. The significance of
these findings for disease development is now testable.
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somes initially accumulate in the stroma of the highly vascularized
choroid plexus, between a layer of fenestrated endothelia and a
layer of epithelia that produce cerebrospinal fluid (CSF). The
resulting inflammatory response disseminates from the choroid
plexus via the microvasculature into the parenchyma in three
characteristic phases: leptomeningitis, early meningoencephalitis,
and encephalitis. According to the current paradigm, trypanosomes invade the brain parenchyma only at the final stages of the
disease, when meningoencephalitis is fully established. Both
histopathology and composition of the inflammatory infiltrate
observed in the murine model mimic autopsy findings in HAT
patients [11,15–18].
African trypanosomes (T. brucei spp.) upregulate ICAM-1,
VCAM-1 and E-selectin expression in brain and non-brain
endothelial cells [19,20]. Our studies using human brain
microvascular endothelial cells (HBMEC) as a blood brain
barrier (BBB) model show a functional link between trypanosome cysteine proteases, Gaq-mediated calcium signaling, and

Introduction
African trypanosomes replicate at the tsetse fly bite site before
migrating from the skin via the lymphatic system into the
bloodstream to infect the spleen, liver, lymph nodes, skin, heart,
eyes, and endocrine system [1,2]. If untreated during the early
stage (Stage-1), the parasites later produce central nervous system
(CNS) disease (Stage-2), a process that takes months to years with
T. b. gambiense (West African) and weeks to months with T. b. rhodesiense (East African) sleeping sickness. Human African trypanosomiasis (HAT) associated meningoencephalitis leads to progressive neurologic involvement with concomitant neuropsychiatric
disorders, fragmentation of the circadian sleep-wake cycle, and
eventually death [1–3]. Once Stage-2 CNS disease is established,
the parasites are shielded from the many trypanocidal drugs and
the brain may be a source for relapse [4,5].
Longitudinal studies in mice all describe one general progression pattern of late-stage brain histopathology [6–14]. TrypanoPLOS ONE | www.plosone.org
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protease-activated receptor-2 (PAR-2) in BBB transmigration
[21–24]. Increased chemokine/cytokine protein expression with
trypanosome infection and gene-profiling data identified several
candidate pathways as links between brain inflammatory
processes and CNS HAT [1,24,25].
Based on these findings, we hypothesized that African
trypanosomes, either individually or in groups, have the potential
for rapid BBB traversal in vivo. The following intravital microscopy
(IVM) study of the murine cortical microvasculature supports this
hypothesis by showing early BBB crossing and parasites in the
brain parenchyma within hours after entering the bloodstream.

Results
Our studies on the role of cysteine proteases in the pathogenesis
of T. b. brucei 90-13 trypanosomiasis, both in a mouse model and
with in an in vitro model of the BBB, strongly implicated brucipain
in facilitating trypanosome entry into the brain [26]. To verify the
parasites’ potential for CNS entry, mice received inocula of 105 or
106 Tbb-O BSF to increase the likelihood of parasite detection in
the brain by IVM. Assuming a total blood volume of 1.6 mL in a
23 g C57Bl6 mouse, an inoculum of 105 and 106 Tbb-O should
result in a respective parasitemia of 6.36104 and 6.36105
parasites/mL immediately post infection, numbers that exceed
the initial parasitemia generated by the bite of a single infected
Tsetse fly, but are typically reached in natural infections of
livestock animals (T. b. brucei) or humans (T. b. rhodesiense). Other
than the expected lower parasite numbers observed after
administration of 105 trypanosomes, IVM revealed no major
differences between the two inoculation regimens, in particular
during the first hours after infection.

Figure 1. Trypanosomes enter the brain parenchyma. One day
post infection with 106 Tbb-O, mice were subjected to craniotomy and
examined by confocal microscopy. The vascular lumen was visualized
by intravenous inoculation of Alexa 647-conjugated BSA (shown in
green). A motile Tbb-O BSF (red) is located adjacent to a PCV. RBCs in
the lumen of the PCV exclude the vascular maker and appear as
negatively stained (dark) streaks. Nuclei were stained with Hoechst
(blue). Bar = 20 mm. Movie S1.
doi:10.1371/journal.pone.0043913.g001

Day 1 Post Infection: T. b. brucei 90-13 Enters the Brain
Parenchyma
Mice infected intravenously with 106 Tbb-O BSF were subjected
to craniotomy and immobilized on the stage of an inverted
confocal microscope for intravital imaging of the cerebral cortex
[27]. Nuclei and the vascular lumen were visualized by
intravenous inoculation of Hoechst 33342 and BSA-Alexa 647,
respectively. Capillaries and postcapillary venules (PCVs), the
morphological correlates of the physiological and neuroimmunological BBB [28], were identified by their respective diameters of
#6 mm and 20–60 mm [29]. PCVs were distinguished from
similarly sized arterioles by the direction of the blood flow [27].
Mice whose meningeal vasculature was injured during craniotomy
exhibited extensive bleeding and were excluded from the study.
None of the mice used for this study exhibited any evidence for
neurological impairment prior to surgery and imaging [30].
Although only low numbers of parasites were observed traveling
with the bloodstream, motile Tbb-O BSF were clearly present in
the brain parenchyma 24 h post infection (Fig. 1, Movie S1).
Occasionally, a trypanosome in process of cell division was seen as
indicated by the presence of two nuclei and two kinetoplasts
(Fig. 2, Movie S2). In contrast to uninfected control animals,
Tbb-O infected mice exhibited individual adherent mononuclear
leukocytes in the cortical microvasculature. These leukocytes
arrested in PCVs and capillaries, the latter of which they
occasionally blocked. Temporary interruption of the blood flow
in a capillary revealed that BSF move with the flagella tip leading
(Fig. 3, Movie S3).
When the lower dose of 105 Tbb-O was inoculated intraperitoneally, intravascular parasites were rare and extravascular
parasites were undetectable by IVM because of constraints
dictated by the field of view through a small cranial window (data
PLOS ONE | www.plosone.org

not shown). The use of Vibratome sections, a technique often used
for neuron imaging or electrophysiological recording of neurons
especially when input-output fibers are also preserved, allowed
examination of a much larger area of tissue than accessible for
IVM through a small cranial window. By screening multiple
vibratome sections of live brain tissue we did find parasites in the
brain parenchyma (Fig. 4).

Day 2 Post Infection: T. b. brucei 90-13 Induces Leukocyte
Recruitment, Vascular Leakage, and Capillary Occlusion
At 48 h after infection, IVM of mice infected intravenously with
106 Tbb-O revealed large numbers of BSF traveling at bloodstream velocity in the cortical microvasculature and many motile
BSF were found in the brain parenchyma and within the
perivascular space (PVS) surrounding PCVs (Fig. 5, Movie S4
and S5). The brain also exhibited signs of microvascular
inflammation: recruitment of leukocytes to PCVs, leakage of the
fluorescent plasma marker into the PVS and surrounding
parenchyma, and focal capillary occlusion.
Similarly, after intraperitoneal inoculation of 105 Tbb-O, the
number of intravascular BSF had increased relative to the previous
day and extravascular parasites were detected more frequently
(Fig. 6, Movie S6 and S7). IVM also revealed a few arrested
mononuclear leukocytes along the wall of PCV and capillaries, but
vascular leakage was less prominent 48 h after infection with 105
compared to 106 parasites (Fig. 7, Movie S8 and S9). Based on
size, shape of nucleus, and amoeboid movement, these mononuclear cells were most likely monocytes.
2
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Figure 2. Trypanosomes divide within the brain parenchyma. DNA staining reveals two nuclei (large Hoechst-stained organelles) and two
kinetoplasts (small Hoechst-stained organelles) within a motile extravascular BSF (red). The figure shows individual frames from an intravital movie
recorded 24 h post infection with 106 Tbb-O. The vascular lumen is green, nuclei are blue. The panels on the right show the two nuclei and two
kinetoplasts of the dividing parasite in the blue channel. Bars = 20 mm. Movie S2.
doi:10.1371/journal.pone.0043913.g002

Figure 3. Trypanosomes travel with the flagellar tip leading. Temporary leukocyte-mediated interruption of the blood flow allows a parasite
to swim freely in a capillary. Note that the negatively stained blood cells (dark) in the vascular lumen become distorted to streaks with increasing
velocity. Two days post infection with 106 Tbb-O BSF. Bars = 20 mm. Movie S3.
doi:10.1371/journal.pone.0043913.g003

PLOS ONE | www.plosone.org
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Figure 4. Brain sections reveal extravascular trypanosomes after low-dose infection. Screening of large areas of brain tissue was required
to detect extravascular (A, arrow) and intravascular (B, arrow) Tbb-O (red) 24 h after infection with 105 BSF. Infected mice were injected with BSAAlexa 647 (green) and the nuclear stain Hoechst (blue) prior to removal of the brain. Immediately after vibratome sectioning, 100 mm slices of live
brain tissue were subjected to ex vivo imaging. Traces of the vascular marker remain visible after sectioning and outline the microvascular lumen.
Bars = 20 mm.
doi:10.1371/journal.pone.0043913.g004

PCV validates previous reports concerning the site of trypanosome
entry into the brain [2] and confirms that parasite entry into the
brain parenchyma is not simply a surgery-induced artifact.

Five Hours Post Infection: T. b. rhodesiense IL 1852 and
T. b. brucei GVR/35 Enter the Brain Parenchyma
Finally, we tested the potential for BBB traversal of the human
CSF isolate T. b. rhodesiense IL1852 and the T. b. brucei-GVR/35
chronic mouse model trypanosome. Five hours after intravenous
inoculation of 106 parasites, motile Tbr-T BSF (Fig. 8, Movie
S10) and Tbb GVR/35-PKH67 (Fig. 8, Movie S11) were found
in the cortical microvasculature and brain parenchyma of the
infected mice. Importantly, arrested leukocytes were rare and
vascular leakage was not evident at this early stage of the infection.

Discussion
IVM allowed us to visualize real time events at the level of the
neurovascular unit (NVU) that occur near the surface of the
cerebral cortex. Nonetheless, with its dense microvasculature,
study of this region of the brain provides a valid snapshot as to
what may occur in other brain areas. It is accepted that
homeostatic interactions between the cellular components of the
NVU (BBB endothelium, astroglia, neurons) are required for
maintaining normal brain function [31–34]. Furthermore, links
between NVU deregulation and CNS disease have been suggested
for multiple sclerosis, Alzheimer’s disease, stroke, certain depression disorders, and microbial infections [35–38]. With the cells of
the NVU being rarely located more than 20–40 mm from a
microvessel, a 15–20 mm trypanosome does not have to travel far
to invade the NVU and infiltrate the brain parenchyma.

Location of Extravascular Trypanosomes
Determination of the location of all extravascular trypanosomes
detected in this study (N = 44) with respect to the cortical
microvascular tree revealed that the overwhelming majority of
the BSF was associated with PCVs (66%) or similar-sized vessels
(7%), few with arterioles (9%), and none with capillaries. The
remaining parasites (18%) had moved too far into the parenchyma
to be classified. The preferential localization of the parasites near

Figure 5. Leukocyte recruitment and vascular leakage. Two days post infection with 106 Tbb-O BSF, the number of both intra- and
extravascular trypanosomes has increased. A) Motile BSF are located in the PVS (arrowhead) surrounding a PCV and in the parenchyma (arrows). B) A
cluster of extravascular BSF can be seen in a PVS (arrowhead), while numerous others have entered the parenchyma (arrows). The vascular marker
BSA-Alexa 647 (shown in green) has leaked into the PVS. The PCVs contain arrested leukocytes (w). The narrow dark streaks in the PCV represent fastmoving blood cells and demonstrate unimpaired blood flow. Bars = 20 mm. Movie S4 and S5.
doi:10.1371/journal.pone.0043913.g005
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Figure 6. Leukocyte recruitment and vascular occlusion. Upper panel: Two days after infection with 105 Tbb-O, a motile BSF (red) is located in
the brain parenchyma near a PCV. While numerous other trypanosomes travel at bloodstream velocity in the PCV, the flow in a neighboring capillary
(top) is impaired by arrested leukocytes. Lower panel: An arrested mononuclear leukocyte occludes a capillary (arrowhead) and diverts the blood flow
into a collateral microvessel (arrow). Some Tbb-O (red) appear distorted due to their high velocity. Bars = 20 mm. Movie S6 and S7.
doi:10.1371/journal.pone.0043913.g006

parenchyma within hours after infection, before a significant level
of microvascular inflammation was detectable. Extravascular BSF
were viable as indicated by motility and cell division and
predominantly associated with PCVs suggesting that early brain
infection occurs by parasite passage across the neuroimmunological BBB. Because we did not pre-label the endothelial cells or
their tight junctions, our studies are not able to determine parasites
in the active act of paracellular crossing.
From our studies we cannot with certainty decipher whether
trypanosomes act alone or require communication amongst a
quorum of parasites to enter the brain. If individual trypanosomes
are capable of early brain entry, our finding challenges the current
paradigm that trypanosomes cross the murine BBB only at the
onset of neurological signs, i.e. days after infection with T. b. brucei
or T. b. rhodesiense and several weeks after infection with T. b. gambiense [43], at a time when the choroid plexus is already parasitized
and meningoencephalitis is established [19,44–47]. On the other
hand, a higher parasitemia may be required as a prerequisite for
CNS entry to initiate the neurological signs associated with Stage2 HAT. Nonetheless, the finding that motile dividing extravascular
Tbb-O and Tbr-T BSF were detectable for at least 3 days post
infection (data not shown) suggests that the parasites can both
cross the BBB and possibly survive in the brain parenchyma. In
support of our finding, Stoppini and colleagues described the use

Nevertheless, although the mechanism of trypanosome passage
across neuroimmunological BBB is likely the same throughout the
brain, the morphological correlate of the NVU in the cortex likely
differs from that in other areas of the brain so that the response of
the parenchyma may be focally distinct. For example, selective
sensitivity of the sleep centers to trypanosome infection would
explain the characteristic clinical signs and pathology of HAT.
Further, iNOS activation was reported to increase throughout the
infection process in certain central compartments of the brain, in
particular the thalamus and hypothalamus where the sleep/wake
regulation is located [39,40]. Therefore, preferential death and
disintegration of trypanosomes in these areas with release of toxins
and inflammatory mediators together with the cytotoxic effect of
NO and its derivatives would cause neuronal injury and altered
signaling and thus contribute to the typical pathogenesis of HAT
[12]. Conversely, areas of low iNOS expression and NO
production such as cortex may support parasite survival.
The murine model supports our hypothesis that the parasites
are able to invade the CNS shortly after entering the bloodstream.
Using fluorescent BSA to define the luminal boundary of brain
microvascular endothelial cells that measure only 0.2–0.3 mm in
thickness [41,42], it was not difficult to define a 5620 mm BSF
trypanosome on the abluminal side of the BBB endothelium. Both
T. b. brucei and T. b. rhodesiense BSF gained access to the brain
PLOS ONE | www.plosone.org
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Figure 7. Leukocyte recruitment to PCVs. The number of arrested mononuclear leukocytes increases between 24 h and 48 h post infection with
105 Tbb-O. In contrast, arrested cells are absent from the cortical microvasculature of an uninfected control mouse. Whereas intravascular Tbb-O are
rare at 24 h, multiple red streaks in the vascular lumen indicate the increase in parasitemia at 48 h post infection. Bars = 20 mm. Movie S8 and S9.
doi:10.1371/journal.pone.0043913.g007

[52], the T. b. brucei GVR/35 induced chronic murine disease
reproduces features typically associated with CNS HAT [4].
Recent experiments conducted at the University of York have
shown T. b. brucei GVR/35 BSF in murine brain sections by day 2
post infection (Lorna MacLean, personal communication), and
studies conducted at the University of Glasgow show GVR/35
BSF in the murine brain on day 5 post infection by two-photon
microscopy and on day 8 by bioluminescence imaging with an
IVIS system (Elmarie Myburgh, personal communication). Most
importantly, some Tbr-infected patients in the Soroti region of
Uganda presented with an early onset of neurodysfunction during
Stage-1 HAT [53]. Together with these findings, our data
challenge the current paradigm that T. b. brucei GVR/35 BSF
invade the CNS only between 14–21 days, because mice can be
cured with the non-CNS drug Berenil if treated within 14–21 days,
i.e. before neurological involvement occurs, but not if treated later

of a murine organotypic brain culture to study the intracerebral
phase of T. b. brucei-mediated trypanosomiasis in vitro [48].
Remarkably, the parasites survived for several weeks around the
periphery and within the nervous parenchyma, although the
culture medium alone was toxic to the parasites. The same also
holds true for T. b. rhodesiense IL1852 in human organotypic
cerebral cortex culture (Grab, unpublished observation). Furthermore, dividing parasites after 3 weeks did not per se interfere with
neuronal activity of CNS based on extracellular electrophysiological recordings [48].
Our finding of early brain invasion by Tbb GVR/35-PKH67 is
potentially profound. While Tbr-T and Tbb-O cause acute
infection identical to wild type parasites, the T. b. brucei GVR/
35 strain establishes a chronic CNS infection in mice with survival
rates of up to 35 days [49]. Based on the degree of neuropathological damage, the level of clinical disability as quantified by
reliable grading scales [50,51], and magnetic resonance imaging

Figure 8. Trypanosomes enter the brain parenchyma within hours. Selected frames from intravital movies show motile BSF in the brain
parenchyma 5 h after infection with 106 BSF. Note the absence of arrested leukocytes and leakage of the vascular marker into the surrounding tissue.
Upper panel: A motile Tbr-T BSF (red) is located in the cerebral parenchyma adjacent to a PCV. Lower panel: A motile Tbb GVR/35-PKH67 BSF (green)
can be seen next to a PCV. Intravascular parasites (arrow) are rare. The vascular lumen is red, nuclei are blue. Bars = 20 mm. Movie S10 and S11.
doi:10.1371/journal.pone.0043913.g008
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property of a single parasite, or does the passage across the BBB
require the interaction from a quorum of parasites? It is also
possible that a large parasite load needs to invade the brain to
produce a CNS infection significant enough to produce a CSF
pleocytosis. Perhaps a few parasites manage to enter the brain
during the early stage of infection, but it may take a week or two
for a sufficiently large parasite load to produce CNS disease.
Further, in vitro models suggest that trypanosome traversal across
the BBB may occur bidirectionally [61], which is supported by the
relapses observed in animals after treatment with non-CNS drugs
such as Berenil [62–64]. For our data to be clinically important,
one would expect the parasites to persist in the brain parenchyma.
Considering the dense vascularization of the brain with a mean
intercapillary distance of only 40 mm [65], extravascular trypanosomes can readily be tracked for long periods of time using a
chronic model for brain IVM [66] in combination with
trypanocidal drugs for elimination of intravascular parasites.
Parasites that are inaccessible to IVM analysis because they are
located in deeper layers of the cortex or the white matter, in the
cerebellum or the brain stem, can be monitored with conventional
techniques or ex vivo in live tissue sections.
While our findings have implications for both animal models
and human disease, the only current way to correlate data from
mouse models with those from HAT patients is to detect
trypanosomes and/or white blood cells in the CSF at Stage-2 of
the disease. Because there are presently no methods to directly
visualize trypanosomes in the human CNS, the complex
mechanisms associated with the pathogenesis of HAT are still
poorly understood. It is currently impossible to distinguish Stage-1
from Stage-2 disease on the basis of clinical findings alone and
CSF analysis remains the only accepted method to diagnose CNS
infection. Interestingly, neurological features were recently reported in sleeping sickness patients with Stage-1 disease [53]. Although
the possibility cannot be excluded that systemic infection can
induce CNS symptoms, this study supports our hypothesis in that
trypanosomes may enter the brain during early stages of the
infection and cause mild early neurological symptoms, but that
protective IL-6 and IL-10 mediated immune responses of the host
prevent major damage to the CNS until later stages of the disease
[67]. Our knowledge of the early pathogenesis of HAT, which
includes the role of host genetics (i.e. rodent strain) in brain
susceptibility to early trypanosomes entry, is still in its infancy.
However, the presence of trypanosomes in the brain hours after
infection may be supportive of treating very early Stage-2 disease
with early stage drugs, a notion that has been suggested as
constituting an intermediate stage of infection [3]. As this is the
first IVM demonstration of trypanosomes in the brain parenchyma as early as hours post infection, the significance of this finding
to human disease and the use of Stage-1 drugs must await the
results of future clinical trials including assessment of whether
current Stage-1 drugs have any brain penetration and/or allow/
bolster neuroimmune systems to protect the brain early in disease.
Nevertheless, the observations reported here suggest that some
case failures of Stage-1 drugs may be due to early access to brain
parenchyma by trypanosomes.
During these studies, several precautions were taken to ascertain
that pathophysiological findings could be distinguished from
methodological artifact. Data acquisition based on confocal Zstacks through the 10–15 mm thick meninges in astrocyte-rich
areas showed that microscopic imaging was possible to a depth of
approximately 50 mm. Thus, it was clear that confocal microscopy
would be a suitable methodology to examine in real time, live
extravascular trypanosomes in the cortical microvasculature.
Furthermore, intravital brain microscopy using over one hundred

than 21 days after infection when Berenil is no longer curative
[4,5,52].
The cerebral microvascular system contains two functionally
distinct barriers, the physiological BBB, which is formed by
capillaries and serves as a tight diffusion barrier for solutes, and the
neuroimmunological BBB, which allows diapedesis of immune
cells and plays a unique role in neuroinflammation [28]. Our IVM
observations show that extravascular trypanosomes are predominantly associated with PCVs rather than capillaries or arterioles,
thus validating previous reports [2]. While our current studies do
not reveal the exact route of the parasites to this location, our
hypothesis is that trypanosomes rapidly cross the neuroimmunological BBB and enter the PVS [54]. However, until this event is
documented in real time by further study, alternative possibilities
must be considered. For example, some parasites may conceivably
reach the PVS by following the flow of the CSF from the choroid
plexus. While often considered a hostile environment for
trypanosomes [11,14,19], CSF from Stage-1 and Stage-2 HAT
patients supports the survival of T. b. brucei for 20 and 10 hours,
respectively [55]. This window provides ample time for the
parasites to travel inside the PVS from the choroid plexus all the
way down to the level of PCVs [13,15]. IVM studies in
combination with static microscopic examination are currently
underway to distinguish between these different scenarios.
The cortical microvasculature of trypanosome-infected mice
exhibited arrested mononuclear leukocytes, whose number
appeared to increase with disease progression. Leukocyte arrest
was observed in PCVs and capillaries, but not in arterioles, and
occasionally resulted in microvascular occlusion and focal
interruption of the blood flow. Which leukocyte subpopulation is
associated with microvascular inflammation and/or entry into the
PVS and brain parenchyma remains to be determined. Leukocyte
accumulation was accompanied by vascular leakage into the
surrounding brain parenchyma, the extent of which appeared to
correlate with size of parasite inoculum and time post infection.
While there was no evidence for BBB impairment 5 h post
infection with 106 Tbr-T or 106 Tbb GVR/35-PKH67 BSF, 24 h
post infection with 105 or 106 Tbb-O BSF, or 48 h post infection
with 105 Tbb-O BSF, leakage of fluorescent BSA into the
parenchyma was seen 48 h after inoculation of 106 Tbb-O BSF,
i.e. at the time of leukocyte recruitment to PCV. Interestingly,
different neurotropic microorganisms possess unique mechanisms
for interaction with the BBB [25]. For example, while African
trypanosomes appear to traverse the BBB without inflicting
significant damage [21], the strictly intravascular malaria parasite
Plasmodium can induce severe microvascular inflammation and
coagulation resulting in neurological impairment, coma, and death
[25,56–58]. Using a murine model of cerebral malaria and IVM,
we found that neurological signs are closely correlated with the
recruitment of various immune cell populations to PCVs and
widespread disruption of the neuroimmunological BBB [27].
While the immune response to trypanosome infection awaits
further characterization, our data demonstrate that both T. b. brucei and T. b. rhodesiense enter the brain parenchyma within hours,
long before disruption of the BBB is apparent. Interestingly,
trypanosomes were also found in the cerebrospinal fluid of
monkeys early after infection when Stage-1 drugs were still
effective [59].
Many questions still remain and further clarification of parasite
interactions with the BBB endothelium and underlying CNS
components is needed. Trypanosome passage across the murine
BBB is a complex process that depends on many biological
variables related to parasite subspecies and host genetics [60]. Is
the ability to transmigrate across the BBB early an inherent
PLOS ONE | www.plosone.org
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Balmer [71] and Roger Tsien [72], respectively. The open reading
frame for each fluorescent marker was amplified by PCR using the
following primers:
mOrange/eGFP fwd: 59-aagcttATGGTGAGCAAGGGCGAGGAG-39
mOrange/eGFP
rev:
59-ggatccTTACTTGTACAGCTCGTCCAT-39
tdTomato fwd: 59-cagatatctaagcttATGGTGAGCAAGGGCGAGGAG-39
tdTomato
rev:
59-cagagactaggatccTTACTTGTACAGCTCGTCCCA-39.
The amplified open reading frames for each fluorescent marker
were then sub-cloned into the pHD1034 vector at the HinDIII/
BamHI sites. Each recombinant plasmid was propagated and
amplified in E. coli.

mice infected with brain tropic-pathogens that include Trypanosoma
brucei (this study), murine-infective Plasmodium (Movila, Nacer and
Frevert, manuscript in preparation, and [27]) and Borrelia burgdorferi
(Movila and Frevert, unpublished) has enabled us to distinguish
between pathophysiological disease-associated vascular alterations
and surgery-induced artifacts. Mice with damage to the pial or
cortical vasculature were excluded from the study. Optimization of
excitation conditions under reduced laser power minimized
phototoxicity and bleaching. In addition, precautions implemented to avoid surgery related-artifacts included i) imaging of
microvessels only at the center of the cranial window to avoid
possible artifacts along the perimeter of the craniotomy, ii)
exclusion of pial microvessels in close proximity to the cranial
coverslip, iii) stabilization of body temperature, and iv) minimization of respiration-induced movement of the brain. Using these
procedures, none of the Trypanosoma-infected mice exhibited
evidence for neurological impairment prior to surgery and imaging
[30]. Finally, perhaps the most important confirmation that
parasite entry into the brain parenchyma is not simply a surgeryinduced artifact in the preferential localization of the parasites
near PCVs, a finding validating previous reports concerning the
site of trypanosome entry into the brain [2].
By establishing a method for long-term IVM analysis of CNS
trypanosomiasis through a cranial window, we have set the stage
for future functional studies with molecular markers, knockout
mice, transgenic parasites, and RNAi. These studies will provide a
better understanding of how intracellular signaling events allow
trypanosome entry into the parenchyma and how endothelial
activation, induction of inflammatory processes, cytokine secretion, leukocyte recruitment, and BBB alterations are involved in
disease progression. A better understanding of parasite entry into
the CNS, whether individually or as a group, may lead to novel
therapeutic approaches and targets for treatment of neurological
dysfunction.

Trypanosome Transfection
Ten mg of pHD1034 vector containing cDNAs for each
fluorescent marker was linearized with NotI restriction endonuclease and precipitated with ethanol. The DNA was re-suspended in
10 ml of H2O and mixed with a 100 mL suspension of T. brucei in
Nucleofector T Cell solution (Lonza Inc. Allendale NJ). For
electroporation, 107 parasites were pelleted by centrifugation. The
parasites were pulsed with the Nucleofector program6001. After
pulsing, the parasites were transferred to 24 mL of complete
medium and incubated overnight at 37uC with 5% CO2. To select
for parasites stably expressing the fluorescent proteins, puromycin
was added to the parasites at a concentration of 0.2 mg/ml and
the parasites were aliquoted in a 24 well plate for 7–12 days.
Stably transfected trypanosomes confirmed by fluorescent microscopy and flow cytometry for these studies were maintained in
normal HMI-9 medium. Both Tbr-T and Tbb-O were confirmed
to cause acute infection in mice similar to wild type parasites and
behave like their respective wild type parental strains in acute
mouse models [26]. For example, mice inoculated with 250
fluorescent Tbr show parasitemia within 6 days post infection and
succumb to the disease within 21 days and mice infected with 600
Tbb-O begin to die 13 days after infection (data not shown).

Materials and Methods
Ethics Statement
This study was conducted in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of NYU School of Medicine (protocol number
100651). All surgery was performed under ketamine/xylazine/
acepromazine anesthesia and all efforts were made to minimize
suffering.

Mice and Infection
Four month-old female C57Bl/6 mice (Taconic Farms) were
inoculated into the retroorbital sinus or intraperitoneally with 105
or 106 culture-derived fluorescent Tbr-T, Tbb-O, or Tbb GVR/35PHK67 BSF as indicated for the individual experiments. Mice
were housed in a parasite-free environment on a 12 h light/dark
program and maintained and used in accordance with recommendations in the guide for the Care and Use of Laboratory
Animals.

Trypanosomes
For our in vivo model of experimental CNS infection we chose 1)
the human CSF isolate T. b. rhodesiense IL 1852 [68], 2) T. b. brucei
90-13 bloodstream forms (BSF) [69], a strain previously used to
demonstrate the possible role for brucipain in facilitating
trypanosome entry into the brain [26], and 3) T. b. brucei GVR/
35, a strain that causes a chronic CNS disease in mice [4]. For
visualization by IVM, T. b. brucei GVR/35 BSF were fluorescently
tagged with the cell tracker dye PKH67 (Sigma, St. Louis, MO)
[21] and named Tbb GVR-PKH67 here. Parasites were maintained in mice and readily adapt to in vitro culture [70].

Anesthesia and Craniotomy
At selected times post infection, mice were anesthetized by
intraperitoneal injection of a cocktail of 50 mg/kg ketamine
(Ketaset, Fort Dodge Animal Health, Fort Dodge, IO), 10 mg/kg
xylazine (Rompun, Bayer, Shawnee Mission, KS), and 1.7 mg/kg
acepromazine (Boehringer Ingelheim Vetmedica, St. Joseph, MO)
(KXA mix) as described [73,74] and surgically prepared for
intravital imaging of the brain [75]. After immobilization of the
head in a stereotaxic apparatus (mouse and neonatal rat adaptor;
Stoelting, Wood Dale, IL), the skull was exposed by midline
incision of the skin and a cranial window 4–5 mm in diameter was
generated using a high-speed microdrill (Fine Science Tools,
Foster City, CA). After removal of the bone flap, the exposed Dura
mater was kept moist with gelatin foam (Gelfoam, Pfizer Inc., New
York) until the window was closed with a cover slip glued to the

Construction of Plasmids Encoding Fluorescent Proteins
T. b. brucei 90-13 were engineered to express monomeric
mOrange (Tbb-O) and T. b. rhodesiense IL 1852 BSF to expressing
tandem dimeric tdTomato (Tbr-T). The phD1034 vector and the
plasmids pRSETOrange and tdTomato were gifts from Oliver
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of the PCV exclude the vascular maker and appear as negatively
stained (dark) streaks. Nuclei are blue.
(AVI)

skull [76]. Placement of the cranial window over the parietal
cortex allowed imaging of cortical branches of the anterior
cerebral artery, smaller arterioles down to capillary size, PCV, and
superficial parietal veins that drain into the superior sagittal sinus.

Movie S2 Trypanosomes divide within the brain parenchyma. DNA staining reveals two nuclei (large Hoechst-stained
organelles) and two kinetoplasts (small Hoechst-stained organelles)
within a motile extravascular BSF (red) 24 h post infection with
106 Tbb-O. The vascular lumen is green, nuclei are blue.
(AVI)

Intravital Microscopy
The cortical microvasculature was imaged with an inverted
Leica TCS SP2 AOBS confocal system [73,74]. Microvessels at
the center of the cranial window were chosen for imaging to avoid
possible surgery-related artifacts along the perimeter of the
craniotomy. Meningeal vessels, which are readily identifiable by
their location on the very surface, i.e. in direct contact with the
coverslip, were excluded from the study. Respiration-induced
movement of the brain was minimized by immobilization of the
cover slip on a custom-made stainless steel adapter for the
microscope stage. The body temperature of the animals was
stabilized with a temperature-controlled Ludin chamber attached
to the microscope. Periodic subcutaneous reinjection of KXA mix
allowed intravital microscopic examination of the brain for 1–2
hours as in the past with Plasmodium-infected mice [27]. To
visualize nuclei and the vascular lumen, mice were injected into
the retroorbital sinus with 150 ml of a mixture of 1–2 mg/ml of the
membrane-permeable DNA stain Hoechst 33342 and 5 mg/ml
Alexa 647-conjugated bovine serum albumin (BSA) (Invitrogen,
Carlsbad, CA), respectively. Appropriate laser lines were used to
excite Hoechst (405 nm), tdTomato (543 nm), mOrange
(543 nm), and Alexa 647 (633 nm). Laser power was reduced to
a minimum to minimize phototoxicity and bleaching. Optimized
excitation conditions have allowed us to monitor live fluorescent
parasites for a period of up to 6 h without any apparent effect on
viability [73,74].
Intravital brain microscopy of more than one hundred mice,
conducted in the course of the studies presented here, IVM of
experimental cerebral malaria (Movila, Nacer and Frevert,
manuscript in preparation, and [27]) and neuroborreliosis (Movila
and Frevert, unpublished), has enabled us to distinguish between
disease-associated vascular alterations and surgery-induced artifacts. Mice with damage to the pial or cortical vasculature typically
exhibit extensive bleeding and profuse leakage of the fluorescent
vascular marker. Such animals do not produce useful data and
were excluded from the study.

Movie S3 Trypanosomes travel with the flagellar tip
leading. Temporary leukocyte-mediated interruption of the
blood flow allows a Tbb-O (red) to swim back and forth in a
capillary 48 h post infection with 106 BSF.
(AVI)

Extravascular trypanosomes and leukocyte
recruitment to PCVs. Two days post infection with 106 Tbb-O
BSF, motile BSF are located in the brain parenchyma adjacent to
a PCV. Large numbers of red streaks in the vascular lumen
indicate high parasitemia. A leukocyte adheres to the wall of the
PCV.
(AVI)
Movie S4

Leukocyte recruitment and vascular leakage.
Two days post infection with 106 Tbb-O BSF, a cluster of
extravascular BSF is located in the PVS (lower left), while many
other BSF have entered the parenchyma (upper right). The
vascular marker BSA-Alexa 647 (shown in green) has leaked into
the PVS. The PCV contains arrested leukocytes (dark cells). The
narrow dark streaks in the center of the PCV represent fastmoving blood cells demonstrating unimpaired blood flow.
(AVI)
Movie S5

Movie S6 Leukocyte recruitment and vascular occlusion. Two days after inoculation of 105 Tbb-O, a motile BSF (red)
is located in the brain parenchyma near a PCV. While numerous
other trypanosomes travel at bloodstream velocity in the PCV, the
flow in a neighboring capillary (top) is impaired by arrested
leukocytes.
(AVI)
Movie S7 Leukocyte recruitment and capillary occlusion. An arrested mononuclear leukocyte occludes a capillary and
diverts the blood flow into a collateral microvessel. Tbb-O BSF
(red) become distorted when moving at high velocity. The vascular
lumen is green, nuclei are blue.
(AVI)

Vibratome Sectioning
Vibratome sections of unfixed brain tissue from infected mice
that had been injected with fluorescent markers were used to
facilitate parasite detection at early times post infection. Thick
sections (100–200 mm) were cut with a Leica VT1200 Semiautomatic Vibrating Blade Microtome (Leica Microsystems, Bannockburn, IL) and imaged immediately after transfer into medium.

Movie S8 Leukocyte recruitment after low-dose infection. Intravascular Tbb-O and arrested mononuclear leukocytes
are rare 24 h post infection with 105 BSF.
(AVI)

Image Processing

Movie S9 Leukocyte recruitment after prolonged lowdose infection. The number of arrested mononuclear leukocytes
has increased between 24 h and 48 h post infection with 105 TbbO. Numerous red streaks in the lumen of the PCV indicate the
higher level of parasitemia.
(AVI)

Multiple confocal time series of the cortical microvasculature
were acquired with Leica Confocal Software. Imaris 7.4 and
Imaris Track (Bitplane, Saint Paul, MN), Image-Pro Plus (Media
Cybernetics, Bethesda, MD), AutoDeBlur (Media Cybernetics,
Bethesda, MD), and NIH ImageJ were used for deconvolution and
analysis of time sequences.

Movie S10 Tbr-T BSF in the parenchyma 5 hours post
infection. A motile Tbr-T BSF (red) is located in the brain
parenchyma adjacent to a PCV after infection with 106 BSF. Note
the absence of arrested leukocytes and leakage of the vascular
marker (red) into the surrounding tissue. The vascular lumen is
green, nuclei are blue.
(AVI)

Supporting Information
Movie S1 Trypanosomes enter the brain parenchyma.
One day post infection with 106 Tbb-O, a motile Tbb-O BSF (red) is
located adjacent to a PCV. The vascular lumen is visualized with
Alexa 647-conjugated BSA (shown in green). RBCs in the lumen
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Movie S11 Tbb BSF in the parenchyma 5 hours post
infection. A motile Tbb GVR/35 BSF, labeled with PKH67
(green), can be seen next to a PCV. Intravascular parasites are
rare. Note the absence of arrested leukocytes and leakage of the
vascular marker (red) into the surrounding tissue. Nuclei are blue.
(AVI)
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